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More and more pediatricians are confronted with teen drinking and the problems that result from it. A new trend is the so called “binge-drinking”. 
This means consumption of excessive amounts of alcohol in a very short period of time with the goal of getting drunk as fast as possible. Within 
1 hour after ingestion, alcohol is absorbed in the stomach and small intestine. Toxic effects of alcohol can occur from a plasma concentration 
of 0.5-1 ‰ (= 500-1000 mg/l) or an intake of 600 mg/kg alcohol. This is equal to ingestion of 120 ml liquor (alcohol concentration 30%) in an 
adolescent of 40kg. The effects are caused by a suppression of the central nervous system and they occur faster in younger people than in adults 
due to less extracellular volume. Also individual factors like gender, use of other medications or drugs and drinking habits play a role. All this 
factors can result in a broad spectrum of symptoms (relaxation, altered perception of the environment, prolonged reaction time, amnesia, nausea, 
vomiting and in more severe cases respiratory depression, coma and death). When a child with possible alcohol intoxication is admitted to the 
emergency department, general “APLS” guidelines (Advanced Pediatric Life Support) should be followed. After the “acute” event of the alcohol 
intoxication, multidisciplinary follow-up of the patient is very important. In Belgium, there are data on Antwerp and Ghent university and college 
students. In this group, 12.8 % of male students does ‘binge’ at least weekly. In female students, this percentage is much lower: 3.6%. However, 
no objective data exist on the problem of binge drinking in the younger age groups, where the risk of adverse effects is even higher. Nevertheless, 
among pediatricians there is great concern about this phenomenon. Therefore, a national survey to assess the prevalence of binge drinking in 
minors is conducted at this moment. 
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INTRODUCTION  TOF is a congenital cyanotic heart defect consisting of a large VSD, 
overriding of the aorta, (sub)pulmonary stenosis and hypertrophy of the right ventricle. 
Surgical correction is usually performed within the first year of life. After repair decreased 
exercise performance has been described. Cardiac output (CO) measurement during 
exercise testing is possible via a CO2-rebreathing technique. 
AIM  The aim of our study is to evaluate cardiac output at rest and at maximal exercise in 
patients with TOF compared to children who performed normal exercise test. 
METHOD  Patients with TOF were invited to participate in a prospective study including a 
maximal cycle exercise test with spirometry combined with measurement of CO via the 
Oxycon Pro (Jaeger) system. Our institutional protocol (continuous ramping at 4W/kg) was 
applied. CO was measured at start and 20 seconds after maximal exercise performance. 
Data were compared with children referred with innocent complaints (chest pain) who 
performed a normal exercise test during the investigation period.
RESULTS  34 patients (18 boys) with TOF were included and compared to 36 normal 
exercise tests (19 boys). Groups were matched for gender, age, weight and length; BSA was 
equal. Both groups performed a reliable exercise time, the duration of the exercise being 
significantly shorter in the TOF-group (9.4±2.3min vs 11.7±3.3min, P<0.05). Maximal 
heart rate (HRmax) (177±17bpm vs 188±10bpm), maximal load (95±36W vs 118±51W 
) and V02 max/kg (38.9±7.8ml/kg/min vs 47.7±10.2ml/kg/min) was significantly lower 
in the TOF group (all P<0.05). 57.6% of patients reached anaerobic treshold (AT), which 
is not different from the control group (55.6%). HR at AT was significantly lower in the 
TOF group (164±18bpm vs 175±15bpm, P<0.05). VE/VCO2 slope was equal. At rest, 
investigation of cardiac output showed no difference in Cardiac Index (CI) and stroke volume 
(SV). At maximal exercise, CI was signficantly lower in TOF-patients (10.2±1.6 vs 11.1±1.7, 
P<0.05) whereas SV stayed equal (61±11ml versus 66±10ml) in both groups.
CONCLUSION  Patients with TOF have significantly lower oxygen consumption, HRmax, 
duration and load of maximal exercise test. This is consistent with earlier published data. CO 
measurement via the CO2-rebreathing technique, demonstrates significant difference in CI 
at maximal exercise, SV however is equal. This finding, in association with significant lower 
HR at AT, is in support for chronotropic incompetence being the major factor of exercise 
intolerance in TOF patients.
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CASE DESCRIPTION  The aortic arch, arterial duct and pulmonary arteries have close anatomical 
relationships with the major airways and esophagus. Abnormalities of position and pattern of 
branching of the aorta can cause encirclement and subsequently obstruction of trachea, bronchus 
and esophagus. This encirclement can be complete (vascular ring) or incomplete (vascular sling). 
Depending on the grade of obstruction respiratory symptoms can occur at different ages. We present 
two cases of children with a vascular ring but a different clinical presentation. 
RESULTS  Case 1: a 4 week old girl was referred to our hospital because of progressive inspiratory 
stridor since several weeks, aggravating with agitation. Because of worsening respiratory distress, 
feeding difficulties and hoarseness, she was hospitalized in our neonatal intensive care unit. 
Bronchoscopy demonstrated a severe distal tracheomalacia with intermittent total collaps. Cardiac 
ultrasound showed a double aortic arch with a dominant left arch without associated intracardiac 
abnormalities. This was confirmed by CT angiography. The double arch caused a complete vascular 
ring around the trachea and esophagus with compression on both structures. Micro-array showed 
no 22q11 deletion. At the age of 6 weeks the girl underwent cardiac surgery with separating the two 
arches. In the months thereafter her respiratory symptoms recovered gradually. Case 2: a 2,5 year old 
girl presented at the emergency room with progressive barking cough, hoarseness and subfebrility 
since several hours. According to the parents these symptoms were frequently recurrent with a 
frequency of several days in a week, especially nocturnal. In between there were no complaints. The 
first episode occurred in infancy. Clinical examination revealed no abnormalities besides the obvious 
barking cough. Bronchoscopy demonstrated a severe distal tracheomalacia. Cardiac ultrasound and 
CT angiography showed a double aortic arch producing a vascular ring with compression of esophagus 
and trachea. The right arch was dominant and 2 great arteries originated at each side. There were no 
associated intracardiac malformations and micro-array showed no 22q11 deletion. The girl underwent 
cardiac surgery with separating the two arches. 
CONCLUSION  Vascular rings and slings are known but rare congenital causes of tracheal compression. 
A double aortic arch is the most commonly recognized type of vascular ring. It is associated with 
other cardiovascular anomalies in 20% of cases and there is an association with 22q11 microdeletion 
syndrome and VACTERL-association. Because double aortic arch is the tightest type of vascular ring 
it usually causes symptoms at young age. As we demonstrated in our cases however, we must be 
aware that clinical presentation can be quite various, ranging from severe neonatal inspiratory stridor to 
recurrent barking cough in toddlers. 
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INTRODUCTION  Very little is carried out on iron and hematological status in AN patients. 
Normal serum iron and elevated serum ferritin concentration were the most revelant results 
seen in few studies based on small cohorts of AN patients.In cardiac literature an overload 
of iron stores raises the risk of ischemic heart disease. Because concentrations of serum 
ferritin are directly proportional to intracellular ferritin concentrations, it is considered to 
be the best clinical measure of body iron stores and we used this parameter in our study . 
Iron overload has been found to increase vascular oxidative stress and accelerate arterial 
thrombosis by promotion of oxidized low-density lipoprotein and direct endothelial injury. 
AIM  The aim of this study was to compare in the acute state of undernutrition in anorexics , 
biochemical, endocrine and cardiac parameters between female anorexic adolescents with 
a high ferritin and a normal ferritin. 
METHOD  The study has a prospective design as all patients with anorexia nervosa (AN) admitted to 
our Eating Disorder Unit from 2002 till 2012 were scheduled to undergo a full clinical examination, 
biochemical and endocrine bilan together with a cardiac examination (echocardiographic evaluation + 
12 lead ECG). In total 311 adolescent girls ( 9.8-17.87 years) were referred during the current study 
and all fulfilled the DMS-IV (Diagnostic and Statistical Manual of Mental disorders, 4th edition DSM-IV ) 
criteria ascertained by a child psychiatrist and a paediatric nutritionist .None of the patients had a family 
history of cardiac diseases or of any systemic disease involving the cardiovascular system. Laboratory 
and clinical parameters:Blood samples were drawn for: BUN, creatinine, electrolytes, cholesterol, thyroid 
hormones, insulin growth factor-1, iron, ferritin, zinc, hemoglobin, hematocrite, leukocytes,fibrinogen and 
liver tests. Body mass index (kg/m²) was calculated and curves and centiles were used as reported by 
Rolland-Cachera et al.(1991). 
RESULTS  In total we identified a high ferritin level > 137 ng/ml in 82 of the 311 in the 
anorexic girls (26,4%).Risk factors for developing a high ferritin are: BMI: 14.41 ± 1.59 kg/
m²; HR: 56.01 ± 16.36 bpm; LVM/height 2.7: 23.99 ± 5.25 g/m 2.7; cholesterol: 192.65 
± 50.70 mg/dl; AST: 31.58 ± 12.11 U/L; ALT: 43.93 ± 47.67 U/L, IGF-1: 113.16 ± 74.97 
ng/ml and FT3: 3.08 ± 1.80 pmol/L. The euthyroid sick syndrome was found in 33% of the 
patients with high ferritin versus 18.3% in the normal ferritin group. 
CONCLUSION  A higher ferritin level is correlated with a higher cholesterol level and lower 
FT3 level. Both parameters are cardiovascular risk factors for atherosclerosis. Further 
research is needed.
ϬϴͻZãÙÊÝÖã®¥ÊÄÙþÊ»ÄÙÙ®ÊÃùÊÖã«®
®¹»®ÄÙÄÄÊ½ÝÄãÄ͗ã®Ê½Ê¦®ÄÙÊ½òÄÊøÖ«
J. VAN STEENKISTE, R. DOSSCHE, K. DE GROOTE, K. VANDEKERCKHOVE, J. PANZER, D. DE WOLF / UZ Gent
INTRODUCTION  Cardiomyopathie (CMP), een heterogene groep van structurele en functionele 
afwijkingen van het myocard, is zeldzaam bij kinderen maar gaat gepaard met een hoge mortaliteit. De 
etiologie is verscheiden en vaak erfelijk. Naast geïsoleerde mutaties, neuromusculaire afwijkingen en 
malformatiesyndromen, liggen ook metabole afwijkingen aan de basis van deze pathologie. Gezien de 
ernst en het frequent familiaal voorkomen van CMP, is kennis omtrent de juiste (genetische) etiologie 
belangrijk o.a. in het kader van prenatale diagnostiek. Sinds 2003 wordt daarom in het universitair 
ziekenhuis Gent (UZG) een standaard protocol gebruikt voor uitwerking van CMP.
AIM  Een overzicht creëren van de patiëntenpopulatie met cardiomyopathie gevolgd op de dienst 
kindercardiologie van het UZG met specifieke registratie van klinische en biochemische tekenen van 
afwijkingen in de oxidatieve fosforylatie (oxphos). 
METHOD  Retrospectief dossieronderzoek van kinderen en adolescenten die tussen 2003 en 2011 
gevolgd zijn in het UZG met cardiomyopathie met registratie van klinische presentatie, diagnostische 
resultaten, etiologie (indien gekend) en behandeling. Aan de hand van een literatuurstudie werden 
vervolgens klinische en biochemische criteria opgesteld die onderliggende mitochondriale pathologie 
doen vermoeden. Deze criteria werden toegepast op de onderzoekspopulatie met ongekende etiologie.
RESULTS  Tussen 2003 en 2011 werden 66 patiënten met CMP gevolgd (40 jongens, 26 meisjes). 
De diagnose van CMP werd gesteld tussen 1984 en 2011. Achttien patiënten (27%) zijn reeds 
overleden (leeftijd mediaan 10 maanden, range 6 dagen - 13,6 jaar;). Op het tijdstip van het onderzoek 
in 2011 lag de leeftijd van de nog in leven zijnde patiënten tussen 15 maanden en 29 jaar (mediaan 
11,9 jaar). Hypertrofe cardiomyopathie (HCM) werd aangetroffen bij 32 patiënten (48,5%), gedilateerde 
cardiomyopathie (DCM) bij 27 patiënten (41%). Bij de overige 10% manifesteerde zich een restrictieve 
of een andere niet geclassificeerde vorm (4 linker ventrikel non-compactie, 1 takotsubo cardiomyopathie 
en 1 atypische rechterventrikel cardiomyopathie). De etiologie is gekend bij 33 patiënten (50%) 
en werd onderverdeeld in genetische (25/33,75,6%) en niet-genetische (8/33, 24,2%) oorzaken. 
Binnen de genetische oorzaken werd onderscheid gemaakt tussen geïsoleerde mutaties (8/25, 32%), 
neuromusculaire syndromen (3/25, 12%), malformatiesyndromen (3/25, 12%) en metabole pathologie 
(11/25, 44%). Bij verdere differentiatie van deze metabole pathologie bleek 64% (7/11) veroorzaakt door 
een onderliggend mitochondriaal defect. De opgestelde criteria voor mitochondriale pathologie werden 
toegepast op de patiënten met ongekende etiologie (N=33). Bij 13 van de 33 patiënten zijn er argumenten 
die meer uitgebreid mitochondriaal onderzoek rechtvaardigen. 
CONCLUSION  De presentatie en etiologie van CMP bij kinderen is zeer heterogeen. Stoornissen in 
oxphos zijn relatief frequent en zijn in onze studiepopulatie vermoedelijk ondergediagnosticeerd.
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INTRODUCTION  After the first percutaneous ASD closure in 1975 and material 
improvement, especially with the Lock Clamshell® in 1985 and Amplatzer® devices in 
1995, several teams have published their results. These were limited to small numbers of 
patients and/or long-term evolution was not documented. The purpose of this study was to 
analyze the effectiveness and long-term evolution after percutaneous closure of ASD, PFO 
or fenestration in a large number of children in a single institution
RESULTS  Among 258 patients, the overall failure rate was 6.6% and 17 ASD patients 
were operated due to an ASD to large for device closure in 15 and device embolization in 2 
patients. The success rate was 93.4% with effective device closure in 241 patients. Mean 
age at closure was 8.2+/-4.3 yrs (range 0.5-17.8 years) and weight 29+/-18 kg (range 
3.2-108 kg). Major procedural complications were observed in 5 patients (2%): device 
embolization in 3 cases (2 of them requiring surgery1.2% - 1 device recovered by cath), 
pericardial effusion requiring drainage in 1 case (0.4%) and the occurrence of stroke in 
1 Fontan patient after fenestration closure (0.4%). Minor complications consisted mainly 
of transient arrhythmias (5.4%) with either spontaneous resolution or under medication. 
The major strength of this study was a complete follow-up (clinical evaluation, EKG, Echo) 
obtained in 98.8 % of the patients (mean FU 5.5+/-3.3 years, range: 0.1-12.2 years). This 
long-term evaluation showed no complication and the clinical benefit of ASD closure with 
a decline in the number of symptomatic ASD patients (exercise intolerance, growth delay, 
recurrent respiratory infections) from 47% of patients before the closure to 13% after the 
procedure. Cardiac echo showed a complete occlusion is 74.3% of the patients at hospital 
discharge, and 93.5 % at late follow-up (ASD 94%, PFO 100%, Fenestration 86%).
CONCLUSION  This study is one of the few with extended FU of a large number of pediatric 
patients. Failure, success and complications rates were comparable to those found in the 
literature . Catheter closure was effective with disappearance of clinical symptoms and no 
significant residual shunt on echo. Major procedural complications were rare and long-term 
FU revealed no further complications.
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CASE DESCRIPTION We report a 20-year-old girl in whom the angiographic diagnosis of 
pulmonary atresia with ventricular septal defect and five major aorto-pulmonary collaterals 
(MAPCAs) originating from the descending aorta, but no native central pulmonary arteries, 
was established at birth in the context of 22q11 microdeletion. The control angiography 
at 6 months of age noted the development of multiple intrapulmonary artery stenoses, so 
that multistage surgery or stenting were excluded. The two MAPCAs supplying the lower 
lobe of the right lung are occluded on a recently performed MRI. Since late childhood, she 
has a progressive decrease in exercise capacity probably due to progressive stenosis of 
MAPCAs, failure of collateral growth and an increase in pulmonary vascular resistance. 
Her oxygen saturation is 85% at rest but falls to 50% within 20 seconds of the beginning 
of low-intensity exercise. Symptoms associated to 22q11 deletion syndrome include velo-
pharyngeal insufficiency, hearing loss, learning disabilities, immunodeficiency without 
life-threatening infections until now, and severe scoliosis treated conservatively because 
hemodynamic stability might not be maintained during anesthesia for surgical correction.
CONCLUSION From previous studies, life expectancy without surgery of patients with 
pulmonary atresia and ventricular septal defect associated with MAPCAs is ±50% at age 
1 year and ±8% at age 10 years. This case suggests that, even when adequate collateral 
blood flow permits adult survival, such patients are highly symptomatic and life expectancy 
is very low.
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INTRODUCTION Brugada syndrome (BrS) is a congenital channelopathy that usually presents 
in adulthood. 
AIM Childhood characteristics are less well known, impetus for this report.
METHOD  We present our single centre experience of children with BrS. The data were collected 
retrospectively from 1996 and prospectively from 2006 by the Brugada team at the University Hospital 
of Brussels. Patients aged ≤16 years with documentation of spontaneous or drug induced coved type 
1 Brugada ECG pattern were included. 
RESULTS  Inclusion criteria were met for 43 patients. Median follow up was 2 1/2 years (1 month - 172 
months). Six patients were lost from follow up. Seventeen patients were symptomatic at presentation 
(M 12/ F 6). Median age was 10 years (7 months to 16 years). Presenting symptoms were: syncope 
(13 patients, half of them having an associated conduction disorder), aborted sudden cardiac death (3), 
sudden cardiac death (1). In ten cases, the syncope was brutal. In the remaining 3 patients, the cause 
of syncope was doubtful and ICD implantation in these patients was recommended considering the 
familial background and the repetitive character of the symptoms. 10 patients were proband. 4 had 
a spontaneous type 1 ECG. The circumstances at the occurrence of the symptoms were extremely 
variable. An implantable cardioverter defibrillator (ICD) was implanted in 15 patients. Appropriate shocks 
were administered in two patients. Three patients received inappropriate shocks and one patient had an 
ICD complication. One patient died although an ICD was implanted. Screening of asymptomatic family 
members revealed 27 patients positive for BrS (M 15/F 12). Five were subsequently symptomatic. 
Three patients had proven vasovagal syncope and no ICD was recommended. Two patients were 
referred for an ICD after having a brutal syncope. Ajmaline testing precipitated ventricular fibrillation 
(VF) in 3 patients. One patient had a non-shockable VF requiring extra-corporal membrane oxygenation 
(ECMO) as treatment. An electrophysiological study (EPS) was performed in 28 patients of whom 
17 were asymptomatic family members. VT was non inducible in any of the asymptomatic patients, 
although inducible in 2 out of eleven symptomatic patients. 
CONCLUSION Symptomatic patients were mostly ≤ 12-year-old boys. Indication for ICD implantation 
may be tasking, as most frequent presentation was syncope, often not clear-cut in this population. 1/3 
was previously diagnosed with atrial conduction disturbances, such as sick sinus syndrome or atrial 
standstill, suggesting a common denominator. Patients presenting with these disorders should also be 
worked out for Brugada syndrome. Ajmaline infusion is potentially dangerous and should be reserved 
for academic settings. Follow up of asymptomatic family members is useful on a clinical basis. 
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INTRODUCTION Gestational diabetes (GD) and diabetes type 2 (DT2) during pregnancy 
have been linked to a possible alteration of cardiovascular outcome in neonates. The exact 
mechanisms of this are not fully understood yet but probably involve activation of systemic 
and myocardial growth factor signalling pathways. Recently, definition of GD has been 
revised with the result of an increase of documented cases, requiring or not treatment by 
diet or insulin. 
AIM In this study, we aimed at investigating the effect of GD on cardiac outcome in neonates. 
METHOD  237 neonates born in our institution were prospectively enrolled. 110 were born 
from a mother with- and 127 from a mother without GD. The latest were examined due 
to clinical suspicion of cardiac disease (heart murmure, cyanosis or respiratory distress). 
Transthoracic standardized echocardiography was performed with measurements of 
diastolic septal- (IVSd) and left ventricular wall thickness (LVWTd), aortic- (VAmax), 
pulmonary-(PVmax) and aortic arch (DAomax) flow velocities, respectively. Patency of 
the foramen ovale, of the ductus arteriosus, tricuspidal insufficiency grade I and flow 
acceleration over one or both pulmonary arteries <2 m/sec. were considered normal. 
RESULTS  Gestational age and age at examination were similar in both groups. There 
was no difference between GD- and control group with respect to IVSd, LVWTd, VAmax. 
PVmax was significantly higher in GD group than in controls (P<0,005). 54/237 neonates 
showed structural cardiac anomaly, 18/110 belonging to GD- and 36/127 to control 
group, respectively (p=NS). GD group encountered for 0/13 of patients with isolated VSD, 
13/27 with isolated ASD, 4/6 with myocardial and/or septal hypertrophy and 1/8 with 
miscellaneous anomalies (mitral insufficiency grade I). 
CONCLUSION  Our study shows that, compared with selected neonates screened for 
suspicion of congenital cardiac defect, neonates born from mothers with GD present with 
a substantial incidence of structural cardiac defects, especially with ASD with left-to right 
shunt and myocardial hypertrophy. 
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